Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (N-Term) Peptide
PARK2
Reactivité: Humain
Hôte: Synthetic
BP, BI
Sodium azide
-
- Antigène Tous les produits Parkin (PARK2)
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- 17 amino acids near the amino terminus of human PARK2.
-
-
- Indications d'application
- The peptide is used for blocking the activity of PARK2 Antibody . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚,C.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Reconstitution
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Concentration
- 200 μg/mL
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store PARK2 Peptide at -20°C, stable for one year.
- Date de péremption
- 12 months
-
- Antigène
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Synonymes
- CG10523 Peptide, Dmel\\CG10523 Peptide, Dpark Peptide, SD01679 Peptide, dpk Peptide, AR-JP Peptide, LPRS2 Peptide, PDJ Peptide, PRKN Peptide, Park Peptide, Prkn Peptide, si:ch211-123f21.1 Peptide, zgc:112390 Peptide, pdr-1 Peptide, PARK2 Peptide, parkin Peptide, parkin RBR E3 ubiquitin protein ligase Peptide, Parkinson disease (autosomal recessive, juvenile) 2, parkin Peptide, park Peptide, PRKN Peptide, Prkn Peptide, prkn Peptide, CpipJ_CPIJ014867 Peptide, Park2 Peptide
- ID gène
- 5071
- NCBI Accession
- NP_004553
- OMIM
- 169790969
- UniProt
- O60260
-
Vous êtes ici:
